These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 11270681)
41. Effects of aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatment. Soulis T; Cooper ME; Vranes D; Bucala R; Jerums G Kidney Int; 1996 Aug; 50(2):627-34. PubMed ID: 8840295 [TBL] [Abstract][Full Text] [Related]
42. Aminoguanidine prolongs survival in azotemic-induced diabetic rats. Friedman EA; Distant DA; Fleishhacker JF; Boyd TA; Cartwright K Am J Kidney Dis; 1997 Aug; 30(2):253-9. PubMed ID: 9261037 [TBL] [Abstract][Full Text] [Related]
43. The effects of aminoguanidine on renal changes in a baboon model of Type 1 diabetes. Birrell AM; Heffernan SJ; Kirwan P; McLennan S; Gillin AG; Yue DK J Diabetes Complications; 2002; 16(4):301-9. PubMed ID: 12126789 [TBL] [Abstract][Full Text] [Related]
44. Effect of diabetes and aminoguanidine therapy on renal advanced glycation end-product binding. Youssef S; Nguyen DT; Soulis T; Panagiotopoulos S; Jerums G; Cooper ME Kidney Int; 1999 Mar; 55(3):907-16. PubMed ID: 10027927 [TBL] [Abstract][Full Text] [Related]
45. Reduced tubular cation transport in diabetes: prevented by ACE inhibition. Thomas MC; Tikellis C; Burns WC; Thallas V; Forbes JM; Cao Z; Osicka TM; Russo LM; Jerums G; Ghabrial H; Cooper ME; Kantharidis P Kidney Int; 2003 Jun; 63(6):2152-61. PubMed ID: 12753302 [TBL] [Abstract][Full Text] [Related]
46. Effects of heparin and aminoguanidine on glomerular basement membrane thickening in diabetic rats. Oturai PS; Rasch R; Hasselager E; Johansen PB; Yokoyama H; Thomsen MK; Myrup B; Kofoed-Enevoldsen A; Deckert T APMIS; 1996 Apr; 104(4):259-64. PubMed ID: 8645464 [TBL] [Abstract][Full Text] [Related]
47. Ramipril reduces albuminuria in diabetic rats fed a high protein diet. O'Brien RC; Cooper ME; Allen TJ; Jerums G Clin Exp Pharmacol Physiol; 1989 Aug; 16(8):675-80. PubMed ID: 2529067 [TBL] [Abstract][Full Text] [Related]
48. The effect of urapidil and ramipril on hyperglycemia in streptozotocin diabetic rats. Ittner KP; Zimmermann M; Bucher M; Gessele W; Kees F; Krämer BK; Grobecker HF Naunyn Schmiedebergs Arch Pharmacol; 2000 Jan; 361(1):92-7. PubMed ID: 10651153 [TBL] [Abstract][Full Text] [Related]
49. Expression of the slit-diaphragm protein, nephrin, in experimental diabetic nephropathy: differing effects of anti-proteinuric therapies. Kelly DJ; Aaltonen P; Cox AJ; Rumble JR; Langham R; Panagiotopoulos S; Jerums G; Holthöfer H; Gilbert RE Nephrol Dial Transplant; 2002 Jul; 17(7):1327-32. PubMed ID: 12105259 [TBL] [Abstract][Full Text] [Related]
50. Aminoguanidine pyridoxal adduct is superior to aminoguanidine for preventing diabetic nephropathy in mice. Miyoshi H; Taguchi T; Sugiura M; Takeuchi M; Yanagisawa K; Watanabe Y; Miwa I; Makita Z; Koike T Horm Metab Res; 2002 Jul; 34(7):371-7. PubMed ID: 12189584 [TBL] [Abstract][Full Text] [Related]
51. ACE inhibition salvages the visual loss caused by diabetes. Bui BV; Armitage JA; Tolcos M; Cooper ME; Vingrys AJ Diabetologia; 2003 Mar; 46(3):401-8. PubMed ID: 12687339 [TBL] [Abstract][Full Text] [Related]
52. Transmission electron microscopy and autofluorescence findings in the cornea of diabetic rats treated with aminoguanidine. Yücel I; Yücel G; Akar Y; Demir N; Gürbüz N; Aslan M Can J Ophthalmol; 2006 Feb; 41(1):60-6. PubMed ID: 16462874 [TBL] [Abstract][Full Text] [Related]
53. Analogs of bardoxolone methyl worsen diabetic nephropathy in rats with additional adverse effects. Zoja C; Corna D; Nava V; Locatelli M; Abbate M; Gaspari F; Carrara F; Sangalli F; Remuzzi G; Benigni A Am J Physiol Renal Physiol; 2013 Mar; 304(6):F808-19. PubMed ID: 23136004 [TBL] [Abstract][Full Text] [Related]
54. Davis BJ, Forbes JM, Thomas MC et al. (2004) Superior renoprotective effects of combination therapy with ACE and AGE inhibition in the diabetic spontaneously hypertensive rat. Diabetologia 47:89-97. Biswas SK; de Faria JM; de Faria JB Diabetologia; 2004 Aug; 47(8):1471; author reply 1472. PubMed ID: 15278280 [No Abstract] [Full Text] [Related]
55. The Effect of Treatment With Aminoguanidine, an Advanced Glycation End Product Inhibitor, on Streptozotocin-Induced Diabetic Rats and Its Effects on Physiological and Renal Functions. Jogula RMR; Row AT; Siddiqui AH Cureus; 2023 Jul; 15(7):e42426. PubMed ID: 37637592 [TBL] [Abstract][Full Text] [Related]